Navigation Links
AMRESCO’s New VisiGlo™ Prime and VisiGlo™ Select HRP Chemiluminescent Substrate Kits Offer Long-lasting, High Sensitivity Detection
Date:3/31/2013

Solon, Ohio (PRWEB) March 31, 2013

Chemiluminescent substrates are standard reagents for the detection of horseradish peroxidase (HRP) in Western blotting. Not all substrates perform equally, however. Critical characteristics to consider for chemiluminescent substrate selection are the sensitivity required to detect a target of interest, the stability of the signal generated and the ability to quantify the signal. AMRESCO’s VisiGlo™ HRP Chemiluminescent Substrate Kit with picogram sensitivity is now one of three VisiGlo™ options available after the addition of VisiGlo™ Prime and VisiGlo™ Select HRP Chemiluminescent Substrate Kits to their repertoire. The different formulations, from low to high sensitivity, allow HRP detection across a broad range of Western blotting conditions.

AMRESCO's new VisiGlo™ Prime HRP Chemiluminescent Substrate Kit is ideal for accurate protein quantitation, with a linear dynamic range of signal versus protein concentration encompassing over three orders of magnitude. The substrate has attomolar sensitivity and can detect both low and high abundance protein on a single blot exposure without exhibiting substrate depletion, a phenomenon observed as inverse staining of highly concentrated protein. The chemiluminescent emission from VisiGlo™ Prime is highly stable, lasting hours after substrate incubation to allow time for optimizing exposures. VisiGlo™ Prime is recommended for use with CCD imagers or film.

VisiGlo™ Select HRP Chemiluminescent Substrate Kit combines a broad linear dynamic range and low femtogram sensitivity to enable quantitation of low-abundance targets that other substrates may not reveal. The sensitivity and high signal-to-noise ratio permit target detection with minimal consumption of valuable protein and antibody reagents and allow long exposure times without compromising image quality. The signal generated by VisiGlo™ Select incubation is stable for hours and may be captured by film, CCD and fluorescence-based imaging systems for maximum flexibility.

AMRESCO’s VisiGlo™ chemiluminescent substrates are designed to achieve maximum signal-to-noise ratios in various blotting conditions. VisiGlo™ is best suited for moderate to high abundance protein detection, while VisiGlo™ Select offers the most intense signal for use in blotting with low abundance targets. For sensitivity and accurate quantitation, VisiGlo™ Prime’s wide dynamic linear range is an ideal choice. The chemiluminescent signals of the three VisiGlo™ options are all compatible with CCD and film imaging. VisiGlo™ Select also works with fluorescent imaging systems.

For more information about the VisiGlo™ HRP, VisiGlo™ Prime and VisiGlo™ Select substrates or any other AMRESCO products, visit http://www.amresco-inc.com or call 1-800-448-4442.

AMRESCO is a manufacturer and supplier of high quality biochemicals and reagents for life sciences in applications including molecular biology, proteomics, histology and clinical research. The company is ISO certified to ensure customers receive the highest quality products.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10582786.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PrimeraDx to Co-Develop Companion Diagnostics with Quest Diagnostics
2. Honble Prime Minister Dr. Manmohan Singh Inaugurates TERIs Delhi Sustainable Development Summit (DSDS) 2013 on Global Challenge of Resource-Efficient Growth and Development
3. Burns Engineering Announces Expanded Selection of Miniature Temperature Sensors
4. ExakTime’s GeoTrakker Selected for 2013 Most Innovative Product Award Program
5. Medical University of South Carolina Selects Elseviers Interdisciplinary Care Planning and Clinical Documentation Solution
6. Douglas Harrington, MD Addresses Select Group Of Physicians Regarding Latest Advances In Cardiovascular Risk Assessment
7. Greenwood Genetic Center Selects Cartagenia BENCHlab NGS, CNV Solutions for Clinical Data Analysis
8. Greenphires ClinCard Technology Platform selected by Bavarian Nordic for Major Vaccine Trial
9. OPX Biotechnologies Selected as Innovation Pioneer at IHS CERAWeek
10. New York Genome Institute Selects Exemplar LIMS to Manage Next Gen Sequencing Labs
11. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... discussions on a range of subjects including policies, debt and ... Poloz. Speaking at a lecture to the Canadian ... to the country,s inflation target, which is set by both ... "In certain areas there needs to be ... why not sit down and address strategy together?" ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):